Searches , social queries for PARTIAL AGONIST

Search references for PARTIAL AGONIST. Phrases containing PARTIAL AGONIST

See searches and references containing PARTIAL AGONIST!

Searches containing PARTIAL AGONIST

PARTIAL AGONIST

  • Partial agonist
  • Agonist drug having partial efficacy at a receptor

    pharmacology, partial agonists are drugs that bind to and activate a given receptor, but have only partial efficacy at the receptor relative to a full agonist. They

    Partial agonist

    Partial agonist

    Partial_agonist

  • Dopamine agonist
  • Compound that activates dopamine receptors

    ergoline agonists are cabergoline and bromocriptine and examples of non-ergoline agonists are pramipexole, ropinirole and rotigotine. Ergoline agonists have

    Dopamine agonist

    Dopamine agonist

    Dopamine_agonist

  • Agonist
  • Chemical which binds to and activates a biochemical receptor

    agonist for the target receptor. It might be argued that the endogenous agonist is simply a partial agonist in that tissue. An irreversible agonist is

    Agonist

    Agonist

    Agonist

  • Agonist-antagonist
  • Type of drug

    it occupies a small proportion of receptors. On the other hand, a partial agonist does not have the ability to fully activate the receptors to where

    Agonist-antagonist

    Agonist-antagonist

    Agonist-antagonist

  • Aripiprazole
  • Atypical antipsychotic medication

    whose principal pharmacological action is as a functionally selective partial agonist at dopamine D2 receptors, stabilizing dopamine activity by enhancing

    Aripiprazole

    Aripiprazole

    Aripiprazole

  • TAAR1
  • Protein found in humans

    TAAR1 full agonist RO5256390, the TAAR1 partial agonist RO5263397, and the TAAR1 antagonists EPPTB and RTI-7470-44. Selective TAAR1 agonists are used in

    TAAR1

    TAAR1

    TAAR1

  • Serotonin receptor agonist
  • Neurotransmission-modulating substance

    are 5-HT1A receptor partial agonists. Flibanserin, a drug used for female sexual dysfunction, is a 5-HT1A receptor partial agonist. Many atypical antipsychotics

    Serotonin receptor agonist

    Serotonin receptor agonist

    Serotonin_receptor_agonist

  • List of investigational antipsychotics
  • Investigational antipsychotics

    Brilaroxazine (RP-5000; RP-5063; oxaripiprazole) – dopamine D2 receptor partial agonist, serotonin 5-HT2A receptor antagonist, and other actions – schizophrenia

    List of investigational antipsychotics

    List_of_investigational_antipsychotics

  • Opioid
  • Class of analgesic drug

    Dezocine—agonist/antagonist Pentazocine—agonist/antagonist Phenazocine Buprenorphine—partial agonist Dihydroetorphine Etorphine Butorphanol—agonist/antagonist

    Opioid

    Opioid

    Opioid

  • Receptor antagonist
  • Type of receptor ligand or drug that blocks a biological response

    bound, however, antagonists inhibit the function of agonists, inverse agonists, and partial agonists. In functional antagonist assays, a dose-response curve

    Receptor antagonist

    Receptor antagonist

    Receptor_antagonist

  • GABAA receptor agonist
  • Hallucinogenic drug

    A GABAA receptor agonist is a drug that acts as an orthosteric agonist of the GABAA receptor, the major signaling receptor of the inhibitory neurotransmitter

    GABAA receptor agonist

    GABAA receptor agonist

    GABAA_receptor_agonist

  • Alpha-adrenergic agonist
  • Class of drugs

    partial α1 agonist and light-controlled mydriatic) Methoxamine Midodrine Metaraminol Phenylephrine Amidephrine Sdz-nvi-085 [104195-17-7]. α2 agonist:

    Alpha-adrenergic agonist

    Alpha-adrenergic agonist

    Alpha-adrenergic_agonist

  • RO5203648
  • Pharmaceutical compound

    trace amine-associated receptor 1 (TAAR1) partial agonist. It is a potent and highly selective partial agonist of both rodent and primate TAAR1. The drug

    RO5203648

    RO5203648

    RO5203648

  • Buprenorphine
  • Opioid used to treat pain and opioid use disorder

    are Schedule III controlled substances. Buprenorphine acts as an agonist, partial agonist, or antagonist at different opioid receptors. It relieves opioid

    Buprenorphine

    Buprenorphine

    Buprenorphine

  • Cariprazine
  • Atypical antipsychotic medicine

    primarily as a D3 and D2 receptor partial agonist, with a preference for the D3 receptor. It is a partial agonist at the serotonin 5-HT1A receptor and

    Cariprazine

    Cariprazine

    Cariprazine

  • Alpha-7 nicotinic receptor
  • Type of cell receptor found in humans

    711: partial agonist Tilorone Tropisetron: subtype-selective partial agonist; 5-HT3 receptor antagonist WAY-317,538 — selective potent full agonist with

    Alpha-7 nicotinic receptor

    Alpha-7 nicotinic receptor

    Alpha-7_nicotinic_receptor

  • SR-17018
  • Atypical opioid drug

    receptor modulator with unusual actions and effects. It acts as a biased partial agonist of the μ-opioid receptor (MOR), showing strong selectivity for activation

    SR-17018

    SR-17018

    SR-17018

  • List of investigational autism and pervasive developmental disorder drugs
  • Investigational pervasive developmental disorder drugs

    Brexpiprazole (Rexulti) – dopamine D2 and D3 receptor partial agonist, serotonin 5-HT1A receptor partial agonist, serotonin 5-HT2A 5-HT2B, and 5-HT7 receptor antagonist

    List of investigational autism and pervasive developmental disorder drugs

    List_of_investigational_autism_and_pervasive_developmental_disorder_drugs

  • Motivation-enhancing drug
  • Drug increasing motivation in humans

    (NRIs), and antipsychotics (which are dopamine receptor antagonists or partial agonists). Cannabinoids, for instance those found in cannabis, have also been

    Motivation-enhancing drug

    Motivation-enhancing drug

    Motivation-enhancing_drug

  • Mu-opioid receptor
  • Class of opioid receptors found in humans

    (or antagonist) Oliceridine Pentazocine (or antagonist) Tramadol (or partial agonist) 7-Hydroxymitragynine MEB-1170 Oliceridine (TRV130) PZM21 SHR9352 SR-15099

    Mu-opioid receptor

    Mu-opioid receptor

    Mu-opioid_receptor

  • NMDA receptor
  • Glutamate receptor and ion channel protein found in nerve cells

    weak partial agonists Homoquinolinic acid – synthetic glutamate site partial agonist N-Methyl-D-aspartic acid (NMDA) – synthetic glutamate site partial agonist

    NMDA receptor

    NMDA receptor

    NMDA_receptor

  • Inverse agonist
  • Agent in biochemistry

    inverse agonist is a drug that binds to the same receptor as an agonist but induces a pharmacological response opposite to that of the agonist. A neutral

    Inverse agonist

    Inverse agonist

    Inverse_agonist

  • Opioid antagonist
  • Receptor antagonist that acts on one or more of the opioid receptors

    used, opioid full agonists, these drugs are generally considered to be antagonists for practical purposes. The weak partial agonist effect can be useful

    Opioid antagonist

    Opioid antagonist

    Opioid_antagonist

  • Nicotinic agonist
  • Drug that binds to and activates nicotinic acetylcholine receptors

    A nicotinic agonist is a drug that mimics the action of acetylcholine (ACh) at nicotinic acetylcholine receptors (nAChRs). The nAChR is named for its

    Nicotinic agonist

    Nicotinic_agonist

  • List of investigational generalized anxiety disorder drugs
  • Investigational generalized anxiety disorder drugs

    partial agonist [5] Ulotaront (SEP-363856; SEP-856) – trace amine-associated receptor 1 (TAAR1) agonist and serotonin 5-HT1A receptor partial agonist

    List of investigational generalized anxiety disorder drugs

    List_of_investigational_generalized_anxiety_disorder_drugs

  • Bretazenil
  • Chemical compound

    to benzodiazepine binding sites where it acts as a partial agonist. Its profile as a partial agonist and preclinical trial data suggests that it may have

    Bretazenil

    Bretazenil

    Bretazenil

  • MRK-409
  • Abandoned drug

    MRK-409, also known as MK-0343, is a GABAA receptor partial agonist. It was designed to be a non-sedative anxiolytic, however its development was halted

    MRK-409

    MRK-409

    MRK-409

  • List of investigational anxiety disorder drugs
  • Investigational anxiety disorder drugs

    serotonin 5-HT1A receptor partial agonist and other actions [25] BW-723C86 – serotonin 5-HT2B and 5-HT2C receptor agonist [26] Cannabidiol dry powder

    List of investigational anxiety disorder drugs

    List_of_investigational_anxiety_disorder_drugs

  • List of investigational substance-related disorder drugs
  • Investigational substance-related disorder drugs

    dopamine D3 receptor partial agonist – smoking withdrawal Brenipatide (LY-3537031) – glucagon-like peptide-1 (GLP-1) receptor agonist, gastric inhibitory

    List of investigational substance-related disorder drugs

    List_of_investigational_substance-related_disorder_drugs

  • Dopamine receptor D2
  • Main receptor for most antipsychotic drugs

    a partial agonist and potentiates dopamine-mediated prolactin secretion in lactotrophs. LSD is also a 5-HT2A agonist. OSU-6162 – also 5-HT2A partial agonist

    Dopamine receptor D2

    Dopamine receptor D2

    Dopamine_receptor_D2

  • AQW-051
  • Nicotinic agonist medication

    AQW-051 also known as VQW-765 is an orally available, highly selective partial agonist of the alpha-7 nicotinic receptor (nAChR) developed by Novartis as

    AQW-051

    AQW-051

    AQW-051

  • Drug antagonism
  • Medicine preventing a biological response

    smooth muscle contraction. In the presence of a full agonist exerting its maximal effect, a partial agonist can behave like a competitive antagonist to lower

    Drug antagonism

    Drug_antagonism

  • List of investigational antidepressants
  • List of pharmaceutical drugs under clinical development for treatment of depression

    (Cyclurad; NRX-101) – ionotropic glutamate NMDA receptor glycine site partial agonist and atypical antipsychotic (non-selective monoamine receptor modulator)

    List of investigational antidepressants

    List_of_investigational_antidepressants

  • 4-PIOL
  • Pharmaceutical compound

    high-efficacy partial agonist in some systems. It does not appear to desensitize GABAA receptors, which is in contrast to higher-efficacy agonists. This property

    4-PIOL

    4-PIOL

    4-PIOL

  • Beta1-adrenergic agonist
  • Examples include: Denopamine (selective β1 agonist) Dobutamine (β1>β2 agonist) Xamoterol (β1 partial agonist) Epinephrine (non-selective) Norepinephrine

    Beta1-adrenergic agonist

    Beta1-adrenergic_agonist

  • 5-HT receptor
  • Class of transmembrane proteins

    Farnsworth NR (August 2005). "Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro". Brain Research. Molecular Brain Research

    5-HT receptor

    5-HT receptor

    5-HT_receptor

  • 5-HT2A receptor
  • Subtype of serotonin receptor

    receptors, and Z3517967757. Quipazine – 5-HT2A agonist but also potent 5-HT3 agonist. SN-22 – partial agonist at all three 5-HT2 subtypes Some benzazepines

    5-HT2A receptor

    5-HT2A receptor

    5-HT2A_receptor

  • Varenicline
  • Nicotinic receptor agonist

    treatment of dry eye syndrome. It is a nicotinic acetylcholine receptor partial agonist. When activated, this receptor leads to the release of dopamine in

    Varenicline

    Varenicline

    Varenicline

  • Mitragyna speciosa
  • Species of plant

    7-hydroxymitragynine) that bind to opioid receptors, mostly as a partial agonist of the μ-opioid receptor. Kratom can also be subjectively stimulating

    Mitragyna speciosa

    Mitragyna speciosa

    Mitragyna_speciosa

  • BP1.4979
  • Pharmaceutical compound

    withdrawal. It is taken orally. The drug acts as a highly potent weak partial agonist of the dopamine D3 receptor (Ki = ~1 nM; EC50Tooltip half-maximal effective

    BP1.4979

    BP1.4979

    BP1.4979

  • Κ-Opioid receptor agonist
  • Drug class

    A κ-opioid receptor agonist, or simply KOR agonist or kappa agonist, is a drug which acts as an agonist of the κ-opioid receptor (KOR), the target of

    Κ-Opioid receptor agonist

    Κ-Opioid receptor agonist

    Κ-Opioid_receptor_agonist

  • Muscimol
  • Naturally occurring sedative and hallucinogen

    subunit-containing GABAA receptors. It is also a potent GABAA-ρ receptor partial agonist and a weak GABA reuptake inhibitor. The drug is inactive at the GABAB

    Muscimol

    Muscimol

    Muscimol

  • Intrinsic activity
  • Measure of relative response to a drug

    described as high efficacy partial agonists, as a partial agonist with efficacy over ≈80-90% is indistinguishable from a full agonist in most assays. Similarly

    Intrinsic activity

    Intrinsic activity

    Intrinsic_activity

  • Thio-4-PIOL
  • Pharmaceutical compound

    is a GABAA receptor weak partial agonist or antagonist related to 4-PIOL. The drug acts as a weak partial agonist or antagonist of the GABAA receptor

    Thio-4-PIOL

    Thio-4-PIOL

    Thio-4-PIOL

  • Beta-adrenergic agonist
  • Medications that relax muscles of the airways

    Beta adrenergic agonists or beta agonists are medications that relax muscles of the airways, causing widening of the airways and resulting in easier breathing

    Beta-adrenergic agonist

    Beta-adrenergic agonist

    Beta-adrenergic_agonist

  • Serotonin 5-HT2A receptor agonist
  • Drug class

    A serotonin 5-HT2A receptor agonist, or simply 5-HT2A agonist, is a drug which acts as an agonist of the serotonin 5-HT2A receptor. The serotonin 5-HT2A

    Serotonin 5-HT2A receptor agonist

    Serotonin 5-HT2A receptor agonist

    Serotonin_5-HT2A_receptor_agonist

  • GABA receptor agonist
  • Category of drug

    A GABA receptor agonist is a drug that is an agonist for one or more of the GABA receptors, producing typically sedative effects, and may also cause other

    GABA receptor agonist

    GABA receptor agonist

    GABA_receptor_agonist

  • RO5073012
  • Pharmaceutical compound

    low-efficacy partial agonist of the trace amine-associated receptor 1 (TAAR1) which has been used in scientific research. TAAR1 partial agonists like RO5073012

    RO5073012

    RO5073012

    RO5073012

  • List of antidepressants
  • (Exxua) – 5-HT1A receptor partial agonist and α2-adrenergic receptor antagonist Opipramol (Insidon) — σ1 receptor agonist, other actions Tianeptine (Stablon

    List of antidepressants

    List_of_antidepressants

  • LY-178210
  • Pharmaceutical compound

    is a selective and highly potent serotonin 5-HT1A receptor partial agonist. It has an affinity (Ki) of 0.67 nM for the serotonin 5-HT1A receptor

    LY-178210

    LY-178210

    LY-178210

  • Nalbuphine
  • Opioid analgesic

    doses. Nalbuphine is a mixed agonist/antagonist opioid modulator. Specifically, it acts as a moderate-efficacy partial agonist or antagonist of the μ-opioid

    Nalbuphine

    Nalbuphine

    Nalbuphine

  • Receptor modulator
  • Substance that binds to and regulates the activity of chemical receptors

    modulators are categorized in the Agonist, Partial Agonist, Selective Tissue Modulators, Antagonist, and Inverse Agonist categories in terms of the effect

    Receptor modulator

    Receptor_modulator

  • 5-HT1A receptor
  • Serotonin receptor protein distributed in the cerebrum and raphe nucleus

    atypical antipsychotics like lurasidone and aripiprazole are also partial agonists at the 5-HT1A receptor and are sometimes used in low doses as augmentations

    5-HT1A receptor

    5-HT1A receptor

    5-HT1A_receptor

  • Allosteric modulator
  • Substance that binds to a receptor to change its response to stimuli

    can be complicated. A modulator may function as a partial agonist, meaning it doesn't need the agonist it modulates to yield agonistic effects. Also, modulation

    Allosteric modulator

    Allosteric_modulator

  • Volume of distribution
  • Theoretical drug measure in pharmacology

    (biochemistry) Excitatory Agonist Endogenous agonist Irreversible agonist Partial agonist Superagonist Physiological agonist Inhibitory Antagonist Competitive

    Volume of distribution

    Volume_of_distribution

  • 7-Hydroxymitragynine
  • Atypical opioid analgesic

    μ-opioid receptors (MOR) than mitragynine. It acts primarily as a partial agonist at μ-opioid receptors while antagonizing δ- and κ-opioid receptors;

    7-Hydroxymitragynine

    7-Hydroxymitragynine

    7-Hydroxymitragynine

  • Analgesic
  • Drugs used to achieve relief from pain

    a partial agonist of the μ-opioid receptor, and tramadol is a serotonin–norepinephrine reuptake inhibitor (SNRI) with weak μ-opioid receptor agonist properties

    Analgesic

    Analgesic

    Analgesic

  • IC50
  • Half maximal inhibitory concentration

    higher concentration of inhibitor leads to lowered agonist activity. IC50 value increases as agonist concentration increases. Furthermore, depending on

    IC50

    IC50

    IC50

  • Cannabinoid
  • Compounds found in cannabis

    (CBN) is a mildly psychoactive cannabinoid acting as a low-affinity partial agonist at CB1 and CB2 receptors. CBN interacts with other neurotransmitter

    Cannabinoid

    Cannabinoid

    Cannabinoid

  • Long-acting beta-adrenoceptor agonist
  • Drug prescribed for asthma patients

    Long-acting β adrenoceptor agonists (LABAs) are beta-adrenergic agonists usually prescribed for moderate-to-severe persistent asthma and chronic obstructive

    Long-acting beta-adrenoceptor agonist

    Long-acting beta-adrenoceptor agonist

    Long-acting_beta-adrenoceptor_agonist

  • Desmethylclozapine
  • Active metabolite of the drug clozapine

    partial agonist at these sites similarly to aripiprazole and bifeprunox. Notably, NDMC has also been shown to act as a potent and efficacious agonist

    Desmethylclozapine

    Desmethylclozapine

    Desmethylclozapine

  • Cannabinoid receptor 2
  • Mammalian protein found in humans

    ligand-induced receptor desensitization and downregulation following repeated agonist application, perhaps causing the receptor to become less responsive to

    Cannabinoid receptor 2

    Cannabinoid receptor 2

    Cannabinoid_receptor_2

  • Dopamine receptor D4
  • Protein-coding gene in the species Homo sapiens

    316: partial agonist, > 8600-fold selective over other dopamine receptor subtypes FAUC 299: partial agonist F-15063: antipsychotic with partial D4 agonism

    Dopamine receptor D4

    Dopamine receptor D4

    Dopamine_receptor_D4

  • Head-twitch response
  • Head movement in rodents upon 5-HT2A receptor activation

    full agonist 8-OH-DPAT suppresses the HTR induced by 5-hydroxytryptophan (5-HTP) or DOI, buspirone, a serotonin 5-HT1A receptor partial agonist, has been

    Head-twitch response

    Head-twitch response

    Head-twitch_response

  • Oxytocin receptor agonist
  • Chemical compound

    An oxytocin receptor agonist is a compound that acts as an agonist of the oxytocin receptor. They include peptides like oxytocin and carbetocin and small-molecules

    Oxytocin receptor agonist

    Oxytocin receptor agonist

    Oxytocin_receptor_agonist

  • Area under the curve (pharmacokinetics)
  • Integral of drug concentration in blood plasma over time

    (biochemistry) Excitatory Agonist Endogenous agonist Irreversible agonist Partial agonist Superagonist Physiological agonist Inhibitory Antagonist Competitive

    Area under the curve (pharmacokinetics)

    Area_under_the_curve_(pharmacokinetics)

  • SR-16435
  • Drug

    SR-16435 is a drug which acts as a potent partial agonist at both the μ-opioid receptor and nociceptin receptor. In animal studies it was found to be

    SR-16435

    SR-16435

    SR-16435

  • PPAR agonist
  • Drug used for the treatment of symptoms of metabolic syndrome

    well as "pan" agonists acting on all three isoforms. The anti-hypertension drug telmisartan is known to have PPAR γ/δ dual partial agonist activity in vivo

    PPAR agonist

    PPAR agonist

    PPAR_agonist

  • Beta2-adrenergic agonist
  • Compounds that bind to and activate adrenergic beta-2 receptors

    Beta2-adrenergic agonists, also known as adrenergic β2 receptor agonists, are a class of drugs that act on the β2 adrenergic receptor. Like other β adrenergic

    Beta2-adrenergic agonist

    Beta2-adrenergic agonist

    Beta2-adrenergic_agonist

  • RO5256390
  • Chemical compound

    agonist for the trace amine associated receptor 1 (TAAR1). It is a full agonist of the rat, cynomolgus monkey, and human TAAR1, but a partial agonist

    RO5256390

    RO5256390

    RO5256390

  • Imidazenil
  • Benzodiazepine drug

    bretazenil. Imidazenil is a highly potent benzodiazepine receptor partial agonist with an unusual profile of effects, producing some of the effects associated

    Imidazenil

    Imidazenil

    Imidazenil

  • RO5263397
  • TAAR1 agonist

    or RO-5263397, is a trace amine-associated receptor 1 (TAAR1) partial or full agonist which is used in scientific research. It is the most well-studied

    RO5263397

    RO5263397

    RO5263397

  • 2,3-Dichlorophenylpiperazine
  • Chemical compound

    serotonin receptor agonist similar to its close analogue 3-chlorophenylpiperazine (mCPP), though it has been shown to act as a partial agonist of the dopamine

    2,3-Dichlorophenylpiperazine

    2,3-Dichlorophenylpiperazine

    2,3-Dichlorophenylpiperazine

  • Bromocriptine
  • Dopamine agonist medication

    autoreceptor locatations) relative to the D2L form, sufficiently low partial agonist activity (i.e. where a molecule binding to a receptor induces limited

    Bromocriptine

    Bromocriptine

    Bromocriptine

  • Imepitoin
  • Anti-convulsant medicine used to treat seizures in dogs

    clonazepam) partial agonist of the benzodiazepine site of the GABAA receptor (up to 12–21% of the maximal potentiation of diazepam, a full agonist of this

    Imepitoin

    Imepitoin

    Imepitoin

  • Razpipadon
  • Chemical compound

    agonist which is under development for the treatment of dementia-related apathy. It is taken orally. Razpipadon acts as a selective partial agonist of

    Razpipadon

    Razpipadon

    Razpipadon

  • TMU4142
  • Pharmaceutical compound

    TMU4142, pindolol is a moderate-efficacy partial agonist of the Go pathways but a very weak partial agonist or antagonist of Gi pathways. TMU4142 produces

    TMU4142

    TMU4142

  • Premazepam
  • Chemical compound

    Premazepam is a drug in the pyrrolodiazepine class. It is a partial agonist of benzodiazepine receptors and was shown in 1984 to possess both anxiolytic

    Premazepam

    Premazepam

    Premazepam

  • Trip killer
  • Drug that blocks hallucinogen effects

    pizotifen, ritanserin, and seganserin, among others. Non-hallucinogenic partial agonists of the serotonin 5-HT2A receptor with sufficiently low intrinsic activity

    Trip killer

    Trip killer

    Trip_killer

  • Tasipimidine
  • Pharmaceutical compound

    affinity for α1-adrenergic receptors, where it appears to act as a partial agonist. Tasipimidine produces anxiolytic, sedative, hypolocomotor, hypotensive

    Tasipimidine

    Tasipimidine

    Tasipimidine

  • Cycloserine/lurasidone
  • Combination drug

    Cyclurad, is a combination formulation of the antibiotic D-cycloserine, a partial agonist of the glycine site of the NMDA receptor, and lurasidone, an atypical

    Cycloserine/lurasidone

    Cycloserine/lurasidone

  • L-687,414
  • Pharmaceutical compound

    L-687,414 is a glycine-site NMDA receptor antagonist or low-efficacy partial agonist (EmaxTooltip maximal efficacy ≈ 10%) which is used in scientific research

    L-687,414

    L-687,414

    L-687,414

  • Mitragynine
  • Opioid analgesic compound

    its use to potentially manage symptoms of opioid withdrawal. It is a partial agonist of the μ-opioid receptors; and as such can produce effects similar

    Mitragynine

    Mitragynine

    Mitragynine

  • Hypnotic
  • Drug whose use induces sleep

    selective and potent serotonin 5-HT6 receptor weak partial agonist, serotonin 5-HT7 receptor inverse agonist, and serotonin 5-HT1D receptor ligand, with one

    Hypnotic

    Hypnotic

    Hypnotic

  • Fenoldopam
  • Antihypertensive agent

    synthetic benzazepine derivative acting as a selective D1 receptor partial agonist. Fenoldopam is sometimes used as a short-term antihypertensive agent

    Fenoldopam

    Fenoldopam

    Fenoldopam

  • Glycine receptor agonist
  • considered a full agonist with maximal efficacy, producing an open probability exceeding 95% when the receptor is fully occupied. Partial agonists such as taurine

    Glycine receptor agonist

    Glycine_receptor_agonist

  • Imidazoleacetic acid
  • Pharmaceutical compound

    as a relatively potent GABAA receptor partial agonist and GABAA-ρ receptor antagonist or weak partial agonist. It shows varying activational efficacies

    Imidazoleacetic acid

    Imidazoleacetic acid

    Imidazoleacetic_acid

  • Κ-opioid receptor
  • Protein-coding gene in the species Homo sapiens, named for ketazocine

    Butorphanol – partial agonist Cebranopadol – partial agonist Cyclorphan – full agonist Diprenorphine – non-selective, partial agonist Etorphine – non-selective

    Κ-opioid receptor

    Κ-opioid receptor

    Κ-opioid_receptor

  • SR-15099
  • Pharmaceutical compound

    been replaced with a bromine atom. The drug is a non-competitive partial biased agonist of the μ-opioid receptor (MOR) similarly to SR-17018. It has similar

    SR-15099

    SR-15099

    SR-15099

  • List of miscellaneous 5-HT2A receptor agonists
  • agonism and psychedelic-like effects have been reported. 5-HT2A receptor agonist Partial lysergamide DPCPX LY-341,495 Robalzotan WAY-100635 UH-301 Head-twitch

    List of miscellaneous 5-HT2A receptor agonists

    List of miscellaneous 5-HT2A receptor agonists

    List_of_miscellaneous_5-HT2A_receptor_agonists

  • MDMA
  • Psychoactive drug, often called ecstasy

    potency as an agonist of the human TAAR1. The drug appears to act as a weak partial agonist of the human TAAR1 rather than as an efficacious agonist. In relation

    MDMA

    MDMA

    MDMA

  • Cinnabarinic acid
  • Chemical compound

    two molecules of 3-hydroxyanthranilic acid. It functions both as a partial agonist at type 4 metabotropic glutamate receptors (mGlu4) and as a ligand

    Cinnabarinic acid

    Cinnabarinic acid

    Cinnabarinic_acid

  • BMB-201
  • Serotonergic drug

    compound known as BMB-A39a. This active metabolite acts as a biased partial agonist of the serotonin 5-HT2A and 5-HT2C receptors. BMB-A39a is slightly

    BMB-201

    BMB-201

  • Thio-THIP
  • Pharmaceutical compound

    "GABAA Agonists and Partial Agonists: THIP (Gaboxadol) as a Non-Opioid Analgesic and a Novel Type of Hypnotic1". GABA(A) agonists and partial agonists: THIP

    Thio-THIP

    Thio-THIP

    Thio-THIP

  • NMDA receptor antagonist
  • Class of anesthetics

    glycine binding site: Rapastinel (GLYX-13) (weak partial agonist; IA = ~20%). NRX-1074 (weak partial agonist). 7-Chlorokynurenic acid. 4-Chlorokynurenine

    NMDA receptor antagonist

    NMDA receptor antagonist

    NMDA_receptor_antagonist

  • Isonipecotic acid
  • Pharmaceutical compound

    receptor partial agonist. It consists of a piperidine ring with a carboxylic acid moiety in the iso position. The drug showed moderate-efficacy partial agonism

    Isonipecotic acid

    Isonipecotic_acid

  • List of investigational Parkinson's disease drugs
  • Investigational Parkinson's disease drugs

    PNU-96391A) – serotonin 5-HT2A receptor partial agonist (non-hallucinogenic), dopamine D2 receptor partial agonist, and sigma σ1 receptor ligand (so-called

    List of investigational Parkinson's disease drugs

    List_of_investigational_Parkinson's_disease_drugs

  • F-15063
  • Pharmaceutical compound

    an antagonist at the dopamine D2 and D3 receptors, partial agonist at the D4 receptor, and agonist at the serotonin 5-HT1A receptors. It has greater efficacy

    F-15063

    F-15063

    F-15063

  • Adrenergic agonist
  • Drug that stimulates a response from the adrenergic receptors

    An adrenergic agonist is a drug that stimulates a response from the adrenergic receptors. The five main categories of adrenergic receptors are: α1, α2

    Adrenergic agonist

    Adrenergic_agonist

  • Raphe nuclei
  • Moderate-size cluster of nuclei found in brain stem

    decrease the release of serotonin. The anxiolytic drug Buspirone acts as partial agonist against these receptors. Selective serotonin reuptake inhibitor (SSRI)

    Raphe nuclei

    Raphe nuclei

    Raphe_nuclei

Searches for online references containing PARTIAL AGONIST

PARTIAL AGONIST

Search references containing PARTIAL AGONIST

PARTIAL AGONIST

Search queries for Facebook and twitter posts, hashtags with PARTIAL AGONIST

PARTIAL AGONIST

Follow users with usernames @PARTIAL AGONIST or posting hashtags containing #PARTIAL AGONIST

PARTIAL AGONIST

Online names & meanings

Search queries for Facebook and twitter users, user names, hashtags with PARTIAL AGONIST

PARTIAL AGONIST

Top search, Social media, medium, facebook & news articles containing PARTIAL AGONIST

PARTIAL AGONIST

Searches for Acronyms & meanings containing PARTIAL AGONIST

PARTIAL AGONIST

Searches, Indeed job searches and job offers containing PARTIAL AGONIST

Other words and meanings similar to

PARTIAL AGONIST

Search in online dictionary sources & meanings containing PARTIAL AGONIST

PARTIAL AGONIST